Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2935701

O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C1[C@@H](Cc2ccc(O)cc2)N(Cc2ccnc3ccccc23)C(=O)N1c1ccc(S(=O)(=O)C(F)(F)F)cc1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.65
MMP2 P08253 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
HDAC6 Q9UBN7 4/20 0.34
TACR1 P25103 3/20 0.34
HSD11B1 P28845 1/20 0.33
GAA P10253 1/20 0.33
CASP6 P55212 1/20 0.32
LMNA P02545 1/20 0.32
XIAP P98170 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
ADAMTS4 O75173 1/20 0.32
MMP13 P45452 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3724562 1.00 IGF1R (0.65) IGF1RMMP2PTGDR2HDAC6TACR1
SCHEMBL2934912 0.96 IGF1R (0.70) IGF1RMMP2PTGDR2HDAC6TACR1
SCHEMBL2934906 0.96 IGF1R (0.70) IGF1RMMP2PTGDR2HDAC6TACR1
Trifluoroacetic Acid SCHEMBL3739554 0.95 IGF1R (0.69) IGF1RPTGDR2HDAC6TACR1HSD11B1
SCHEMBL2931273 0.91 IGF1R (0.74) IGF1RMMP2PTGDR2HDAC6TACR1
SCHEMBL2931269 0.91 IGF1R (0.74) IGF1RMMP2PTGDR2HDAC6TACR1
SCHEMBL3724561 0.89 IGF1R (0.63) IGF1RPTGDR2HDAC6TACR1HSD11B1
Trifluoroacetic Acid SCHEMBL3726914 0.88 IGF1R (0.66) IGF1RPTGDR2HDAC6TACR1HSD11B1
Trifluoroacetic Acid SCHEMBL3726949 0.87 IGF1R (0.47) IGF1RHDAC6GAA
Trifluoroacetic Acid SCHEMBL3730823 0.86 IGF1R (0.63) IGF1RPTGDR2TACR1HSD11B1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-B1 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2010-09-22 EP claimed